Multiline treatment of advanced squamous cell carcinoma of the lung: A case report and review of the literature

Figure 3 Images from computed tomography showing the tumor in the right lung and mediastinum in response to therapy. A: Before therapy, imaging performed on May 2, 2013; B: After two cycles of DP therapy, imaging performed on June 7, 2013 and evaluation classified the status as a progressive disease; C: After six cycles of TP therapy, imaging showed that the tumor had shrank significantly. DP: 75 mg/m² docetaxel on day 1 and 75 mg/m² cisplatin on day 1; TP: 100 mg/m² nab-paclitaxel (nab-PC) on days 1, 8 ,and 15, and 75 mg/m² cisplatin on day 1.